Management of the Axilla in the Era of Breast Cancer Heterogeneity

Archive ouverte

de Meric de Bellefon, Maïlys | Lemanski, Claire | Ducteil, Angélique | Fenoglietto, Pascal | Azria, David | Bourgier, Céline

Edité par CCSD ; Frontiers Media -

International audience. Systemic cancer therapies take into account breast cancer (BC) heterogeneity by targeting pathways specifically involved in some BC subtypes. On the other hand, BC intrinsic radiosensitivity is poorly understood and studied. Hence, radiotherapy personalization in BC is still "work in progress". In this review, we will summarize the existing data on the management of axillary lymph nodes in BC, the impact of BC radiotherapy on axillary management, the indications for axillary radiotherapy, and biomarkers to predict patients' outcome (tumor control and late toxicities) after axillary irradiation.

Suggestions

Du même auteur

Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure

Archive ouverte | de Meric de Bellefon, Maïlys | CCSD

International audience. Background and purpose: To assess the long-term outcomes of patients with squamous cell carcinoma of the anal canal (SCCAC) treated with Intensity-Modulated Radiation Therapy (IMRT).Material ...

Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients

Archive ouverte | Riou, Olivier | CCSD

International audience. BACKGROUND:Accelerated partial breast irradiation (APBI) is an option for adjuvant radiotherapy according to ASTRO and ESTRO recommendations. Among the available techniques, volumetric-modula...

The major debate: Micrometastases and breast cancer - To be for nodal irradiation. Le grand débat : cancers du sein pN1mi – pour l’irradiation des aires ganglionnaires

Archive ouverte | Bourgier, Céline | CCSD

International audience. Standard of care in breast cancer management is well-defined. However, some gray zones still exist, in particular adjuvant radiotherapy indications in case of pN1mi breast cancer. Here we pro...

Chargement des enrichissements...